Changes in inflammatory factors, oxidative stress, glucose and lipid metabolism, and insulin resistance in patients with polycystic ovary syndrome

被引:4
|
作者
Zhong, Peiwen [1 ]
Guan, Baoxing [1 ]
Lin, Yanting [1 ]
Zhang, Siyou [1 ]
机构
[1] Foshan First Peoples Hosp, Dept Obstet & Gynecol, Foshan 528000, Peoples R China
关键词
Inflammatory factors; Oxidative stress; Glucose and lipid metabolism; Insulin resistance; polycystic ovary syndrome; DAMAGE; WOMEN;
D O I
10.14715/cmb/2021.67.5.6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polycystic ovary syndrome (PCOS) is a common disease in women, affecting women's menstruation and significantly impacting women's physical and mental health. Studies have shown that insulin resistance has an important relationship with polycystic ovary. It is of great significance to explore the changes of inflammatory factors, oxidative stress, glucose and lipid metabolism, and insulin resistance in patients with PCOS. In the study process, 642 polycystic ovary patients in the first half of 2019 were divided into insulin resistance (n=357) and non-insulin resistance (n=285) groups. Oxidative stress index, glucose, and lipid metabolism index, and inflammatory factors were detected during the study process. The results showed that the levels of hs-CRP, TNF-alpha, and IL-6 in the IR group were 5.9mg/L, 9.2 mu g/L, and 87.2ng /ml, while those in the non-IR group were 4.6mg/L, 6.3 mu g/L and 51.5ng/ml, respectively. Thus, IL-6 and insulin levels maintain a dynamic balance. Low levels of IL-6 can promote insulin secretion, while high levels can inhibit its secretion. The results of this study will provide a specific clinical reference value for the prevention and treatment of polycystic ovary syndrome. Copyright: (C) 2021 by the C.M.B. Association. All rights reserved.
引用
收藏
页码:45 / 50
页数:6
相关论文
共 50 条
  • [21] Insulin resistance in nonobese patients with polycystic ovary syndrome
    Toprak, S
    Yönem, A
    Çakir, B
    Güler, S
    Azal, Ö
    Özata, M
    Çorakçi, A
    HORMONE RESEARCH, 2001, 55 (02) : 65 - 70
  • [22] Assessment of insulin resistance in patients with polycystic ovary syndrome
    Jensterle, M
    Janez, A
    Weber, M
    Jakocijancic, A
    Frost, T
    Pfützner, A
    DIABETES, 2005, 54 : A526 - A526
  • [23] Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome
    Enli, Yasar
    Fenkci, Semin Melahat
    Fenkci, Veysel
    Oztekin, Ozer
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (12) : 1036 - 1039
  • [24] Insulin resistance in polycystic ovary syndrome
    Castro-Acuña, V
    Martínez-Martínez, L
    Cravioto, MD
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2004, 56 (06): : 763 - 772
  • [25] The impact of TLR4 on insulin resistance and inflammatory factors in rats with polycystic ovary syndrome
    Guo, Ying
    Sun, Zhengao
    Liu, Zhuo
    Song, Jingyan
    Wang, Tianqi
    Liu, Danqi
    Liu, Honggen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (11): : 12239 - 12245
  • [26] Insulin resistance in polycystic ovary syndrome
    Prelevic, GM
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 1997, 9 (03) : 193 - 201
  • [27] INSULIN RESISTANCE IN POLYCYSTIC OVARY SYNDROME
    SHOUPE, D
    KUMAR, DD
    LOBO, RA
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1983, 147 (05) : 588 - 592
  • [28] Insulin Resistance and Polycystic Ovary Syndrome
    Moghetti, Paolo
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (36) : 5526 - 5534
  • [29] Oxidative Stress in Polycystic Ovary Syndrome
    Papalou, Olga
    Victor, Victor M.
    Diamanti-Kandarakis, Evanthia
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (18) : 2709 - 2722
  • [30] Polycystic ovary syndrome and insulin resistance
    Ducluzeau, PH
    Laville, M
    Vidal, H
    Pugeat, M
    DIABETES & METABOLISM, 2001, 27 (04) : S7 - S12